Earnings Labs
Immix Biopharma, Inc. logo

Immix Biopharma, Inc. (IMMX)

NASDAQ·Healthcare·Biotechnology

$8.70

-8.71%

Mkt Cap $522.17M

Analyst Ratings

Buy

4

Hold

0

Sell

0

Price Target (3 analysts)

$13.00

Range $12.00$14.00

Implied Upside

+49.4%

Consensus $13.00 vs current $8.70